Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Balaji AminesNSE:BALAMINES -7.44%78 Debt-to-EBITDA is 0.33 as of Mar. 2026, which is 18% below its 10-year median of 0.40. GuruFocus rates NSE:BALAMINES with a GF Score™ of 78/100 and a GF Value™ of ₹1,677.63 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 1,235 Chemicals companies, Balaji Amines ranks better than 79.84% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Balaji Amines's Debt-to-EBITDA or its related term are showing as below:
NSE:BALAMINES'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.04 Med: 0.4 Max: 1.32
Current: 0.45
During the past 13 years, the highest Debt-to-EBITDA Ratio of Balaji Amines was 1.32. The lowest was 0.04. And the median was 0.40.
NSE:BALAMINES's Debt-to-EBITDA is ranked better than 79.84% of 1235
companies
in the Chemicals industry
Industry Median: 2.16
vs NSE:BALAMINES: 0.45
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Balaji Amines Debt-to-EBITDA Related Terms
Balaji Amines Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Balaji Amines's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:BALAMINES vs LIN, SHW, ECL: Debt-to-EBITDA Comparison
For the Specialty Chemicals subindustry, Balaji Amines's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Balaji Amines Debt-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Balaji Amines's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Balaji Amines's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Balaji Amines (NSE:BALAMINES) has a Debt-to-EBITDA of 0.33 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Balaji Amines. This is 18% below median its historical median of 0.40. Over the past decade, Balaji Amines' Debt-to-EBITDA has ranged from 0.04 to 1.32. According to the industry distribution chart, Balaji Amines ranks #249 out of 1235 companies in the Chemicals industry, placing it in the top 20.2%.
Is Balaji Amines' Debt-to-EBITDA too high?
Balaji Amines' current Debt-to-EBITDA of 0.33 is 18% below median its 10-year median of 0.40. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 1.32. The Chemicals industry median Debt-to-EBITDA is 2.16. Balaji Amines' value of 0.33 is 84.7% below this industry median. Based on the distribution chart, Balaji Amines ranks #249 out of 1235 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Balaji Amines has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Balaji Amines' Debt-to-EBITDA compare to LIN and SHW?
According to the Chemicals industry distribution chart, Balaji Amines ranks #249 out of 1235 companies for Debt-to-EBITDA. This places Balaji Amines in the top 20% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.16. Balaji Amines' value of 0.33 is 84.7% below this benchmark. Historically, Balaji Amines' own Debt-to-EBITDA has ranged from 0.04 to 1.32 over the past decade. While the company's 10-year median is 0.40 vs. the industry median of 2.16, Balaji Amines has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Chemicals company?
The median Debt-to-EBITDA among Chemicals companies is 2.16, based on 1,235 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Balaji Amines's current Debt-to-EBITDA of 0.33 is 84.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Balaji Amines. For the Chemicals industry, the median Debt-to-EBITDA is 2.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Balaji Amines's current Debt-to-EBITDA is 0.33, which is 18% below median its own 10-year median of 0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balaji Amines stock overvalued right now?
Based on GuruFocus' analysis, Balaji Amines (NSE:BALAMINES) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,677.63, compared to a current price of ₹2,174.50 — trading 29.6% above its estimated fair value. The current Debt-to-EBITDA is 0.33, which is 18% below median its 10-year median of 0.40 and 84.7% below the Chemicals industry median of 2.16. Balaji Amines' overall GF Score™ is 78/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Balaji Amines (NSE:BALAMINES), the current Debt-to-EBITDA is 0.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Balaji Amines (NSE:BALAMINES) Overvalued in 2026?
Based on GuruFocus' analysis, Balaji Amines stock appears to be overvalued.
The current stock price of ₹2,174.50 is trading 29.6% above its estimated GF Value™ of ₹1,677.63.
GuruFocus considers Balaji Amines to be Modestly Overvalued.
Key valuation signals for NSE:BALAMINES:
Debt-to-EBITDA: 0.33 (18% below median its 10-year median of 0.40)
GF Value™: ₹1,677.63 vs. price of ₹2,174.50 (29.6% above fair value)
Industry Position: 84.7% below the Chemicals median (#249 of 1235)
No single metric tells the full story. See the NSE:BALAMINES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Balaji Amines Ltd is engaged in the manufacture and sale of aliphatic amines, speciality chemicals, and their derivatives. The Company's manufacturing facilities operate through Distributed Control Systems (DCS), indigenous process technologies, and a Zero Liquid Discharge (ZLD) framework. The business operates through the Chemicals and Hotel segments, with the Chemicals segment generating maximum revenue. Its products include amines such as Mono Methyl Amine (MMA), Di-Methyl Amine (DMA) and others; speciality chemicals such as Morpholine, Acetonitrile (ACN), and others; and amine derivatives such as Mono-Methyl Amine Hydrochloride (MMA HCL), Di-Methyl Amine Hydrochloride (DMA HCL) and others. Geographically, the Company generates maximum revenue from India.
78GF Score
Get the complete analysis for NSE:BALAMINES
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:BALAMINES has been successfully added to your 
